Pulmonary vascular disease in a failed Fontan patient with Down's syndrome

Gen Thorac Cardiovasc Surg. 2018 May;66(5):299-302. doi: 10.1007/s11748-017-0809-6. Epub 2017 Aug 10.

Abstract

It is well known that Down's syndrome is a strong risk factor for mortality after Fontan operations. We performed two lung biopsies in a Down's syndrome patient who underwent staged Fontan operations. The pathological findings revealed severe pulmonary arterial hypertrophy and a quantitative real-time polymerase chain reaction revealed the overexpression of endothelin and a decline in the eNOS level at the Fontan operation. Although the preoperative hemodynamic studies revealed that all of the criteria for Fontan had been fulfilled, the patient died of acute cardiac insufficiency, 35 days after the Fontan operation.

Keywords: Down’s syndrome; Endothelial nitric oxide synthase; Endothelin system; Fontan circulation.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Child, Preschool
  • Down Syndrome / complications*
  • Fatal Outcome
  • Fontan Procedure*
  • Heart Failure
  • Heart Septal Defects / surgery
  • Hemodynamics / physiology
  • Humans
  • Lung Diseases / physiopathology
  • Lung Diseases / surgery*
  • Male
  • Nitric Oxide Synthase Type III / metabolism
  • Pulmonary Artery / surgery
  • Pulmonary Circulation / physiology
  • Risk Factors
  • Tetralogy of Fallot / surgery
  • Treatment Failure
  • Vascular Diseases / pathology*
  • Vascular Diseases / physiopathology

Substances

  • NOS3 protein, human
  • Nitric Oxide Synthase Type III

Supplementary concepts

  • Atrioventricular Septal Defect